Pilot and Feasibility Studies (Dec 2022)

Social network-based group intervention to promote uptake of cervical cancer screening in Uganda: study protocol for a pilot randomized controlled trial

  • Rhoda K. Wanyenze,
  • Joseph K. B. Matovu,
  • Kathryn Bouskill,
  • Margrethe Juncker,
  • Eve Namisango,
  • Sylvia Nakami,
  • Jolly Beyeza-Kashesya,
  • Emmanuel Luyirika,
  • Glenn J. Wagner

DOI
https://doi.org/10.1186/s40814-022-01211-z
Journal volume & issue
Vol. 8, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Introduction Cervical cancer (CC) is the most common cancer and accounts for one quarter of all cancer-related deaths among women in Uganda, where lifetime CC screening is estimated to be as low as 5%. This study will evaluate the feasibility, acceptability, and preliminary efficacy of a social network-based group intervention designed to empower women who have received CC screening to encourage women in their social network to also screen. Methods Forty adult women (index participants) who have recently screened for CC will be recruited, 20 of whom will be randomly assigned to take part in the intervention and 20 to the wait-list control. Each index participant will be asked to recruit up to three female social network members (i.e., alters; maximum total = 120 alters) who have not screened for CC to participate in the study. Assessments (survey and chart abstraction) will be administered at baseline and month 6 to index and alter participants. The primary outcome is CC screening among participating alters, with a secondary outcome being engagement in CC prevention advocacy among index participants. Repeated-measure multivariable regression analyses will be conducted to compare outcomes between the intervention and control arms. Discussion If successful, this intervention model has the potential not only to impact uptake of CC screening and treatment but also to establish a paradigm that can be applied to other health conditions. Trial registration NIH Clinical Trial Registry NCT04960748 (clinicaltrials.gov).

Keywords